From October 1, 2022 to December 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 660,400 shares, representing 0.06% for CNY 19.99 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.75 CNY | +7.01% | +4.06% | -23.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.57% | 3.2B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.